2017
DOI: 10.1158/1078-0432.ccr-17-0408
|View full text |Cite
|
Sign up to set email alerts
|

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Abstract: Li-Fraumeni syndrome (LFS) is an autosomal dominantly inherited condition caused by germline mutations of the tumor suppressor gene encoding p53, a transcription factor triggered as a protective cellular mechanism against different stressors. Loss of p53 function renders affected individuals highly susceptible to a broad range of solid and hematologic cancers. It has recently become evident that children and adults with LFS benefit from intensive surveillance aimed at early tumor detection. In October 2016, th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
317
0
37

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

4
4

Authors

Journals

citations
Cited by 405 publications
(355 citation statements)
references
References 73 publications
1
317
0
37
Order By: Relevance
“…Patients with mosaic mutations should also benefit from surveillance protocols, such as those which have recently been elaborated for germline TP53 mutation carriers. These protocols are based, from the first year of age, on abdominal ultrasound every 6 months, annual total body MRI, annual brain MRI and in women from 20 years on annual breast MRI 46. Nevertheless, the benefits of such heavy protocols regardless to the psychological impacts might be questionable in these patients with mosaic TP53 mutations, as one cannot exclude that the mosaic mutation might be restricted to certain tissues.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with mosaic mutations should also benefit from surveillance protocols, such as those which have recently been elaborated for germline TP53 mutation carriers. These protocols are based, from the first year of age, on abdominal ultrasound every 6 months, annual total body MRI, annual brain MRI and in women from 20 years on annual breast MRI 46. Nevertheless, the benefits of such heavy protocols regardless to the psychological impacts might be questionable in these patients with mosaic TP53 mutations, as one cannot exclude that the mosaic mutation might be restricted to certain tissues.…”
Section: Discussionmentioning
confidence: 99%
“…LFS is an autosomal dominant cancer predisposition syndrome caused by germline mutations in the TP53 gene, which encodes the critical TP53 tumor suppressor protein. LFS is characterized by a high risk for a number of tumor types, including acute leukemia (9,12). Indeed, leukemia was one of the defining cancers of LFS in its original descriptions and accounts for 3% to 5% of all LFS cancers (12,13).…”
Section: The Leukemia Predisposition Syndromesmentioning
confidence: 99%
“…For example, if a matched related HSCT is to be used, relatives who test negative for the familial TP53 mutation would be the preferred donors. In addition, knowing the germline TP53 mutation status of the patient may be a consideration in determining pretransplant conditioning regimens, particularly with respect to use of total body irradiation (9). Strategies for tumor surveillance have been described for LFS (7,12,18), but their impact on improving outcomes for those who develop leukemia remains unknown.…”
Section: The Leukemia Predisposition Syndromesmentioning
confidence: 99%
See 1 more Smart Citation
“…These results are controversial, with many citing the “Toronto Protocol” as standard screening, and others suggesting that the risks and benefits of this approach are not well‐enough studied . An expert panel recently published consensus recommendations based upon individual institutional approach …”
Section: Introductionmentioning
confidence: 99%